Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Year-over-year book value per share growth
Latest
-17.95%
↓ 122% vs avg
Percentile
P27
Within normal range
Streak
4 qtr
Consecutive declineDecelerating
Average
83.40%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -17.95% |
| Q2 2025 | -17.71% |
| Q1 2025 | -15.97% |
| Q4 2024 | -12.05% |
| Q3 2024 | -9.30% |
| Q2 2024 | -49.11% |
| Q1 2024 | 1232.38% |
| Q4 2023 | -28.49% |
| Q3 2023 | -80.95% |
| Q2 2023 | 0.00% |
| Q1 2023 | 0.00% |
| Q4 2022 | 0.00% |